Randhawa Simrat Insider Trades

Insider Trading History

Track insider trading activity for Randhawa Simrat. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $8.48M 96,875 shares
Last Trade
Jun 01, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.37M 26,530 shares
$89.45
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $2.67M 30,530 shares
Last Trade
Jun 01, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.37M 26,530 shares
$89.45
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $2.2M 25,102 shares
Last Trade
Jun 01, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.4M 26,530 shares
$90.62
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $0 0 shares
Last Trade
Mar 12, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$2.76M 33,830 shares
$81.48
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $2.96M 33,830 shares
Last Trade
Mar 12, 2026 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 33,830 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $9.3M 106,250 shares
Last Trade
Mar 12, 2026 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.72M 33,830 shares
$80.32
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $13.1M 150,000 shares
Last Trade
Feb 03, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$7.87M 150,000 shares
$52.46
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $350k 4,000 shares
Last Trade
Nov 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$4.16M 109,031 shares
$38.14
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $10.4M 118,750 shares
Last Trade
Nov 14, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.45M 109,031 shares
$40.85
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $9.89M 113,031 shares
Last Trade
Nov 14, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$4.45M 109,031 shares
$40.85
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $8.01M 91,507 shares
Last Trade
Nov 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.11M 87,507 shares
$35.50
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $5.72M 65,341 shares
Last Trade
Nov 13, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$3.22M 87,507 shares
$36.81
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Evp, Head Of R&d
Holding Value $10.2M 116,471 shares
Last Trade
Nov 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$3.11M 87,507 shares
$35.50
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $5.25M 60,000 shares
Last Trade
Sep 23, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.27M 60,000 shares
$37.87
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $13.1M 150,000 shares
Last Trade
Feb 03, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.31M 150,000 shares
$22.07
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $8.75M 100,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.18M 100,000 shares
$21.77
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
CHIEF MEDICAL OFFICER
Holding Value $10.5M 120,000 shares
Last Trade
Jan 24, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.15M 120,000 shares
$17.88
$87.53
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Medical Officer
Holding Value $350k 4,000 shares
Last Trade
Sep 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.4k 2,000 shares
$13.20
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
Chief Medical Officer
Holding Value $2.8k 4,000 shares
Last Trade
Sep 22, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$1.4k 2,000 shares
$0.70
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Chief Medical Officer
Holding Value $175k 2,000 shares
Last Trade
Sep 21, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$26.4k 2,000 shares
$13.20
$87.53

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up